BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

SecurityBBIO / BridgeBio Pharma, Inc.
InstitutionBoothbay Fund Management, Llc
Latest Disclosed Ownership46,981 shares
Latest Disclosed Value $ 3,488,809
Boothbay Fund Management, Llc ownership in BBIO / BridgeBio Pharma, Inc.

On May 15, 2026 - Boothbay Fund Management, Llc filed a 13F-HR form disclosing ownership of 46,981 shares of BridgeBio Pharma, Inc. (US:BBIO) valued at $3,488,809 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of BridgeBio Pharma, Inc.. The current value of the position is $3,076,316 USD.

Boothbay Fund Management, Llc has a history of taking positions in derivatives of the underlying security (BBIO) in the form of stock options. The firm currently holds call options representing 17,000 of underlying shares valued at $1,262,420 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BBIO / BridgeBio Pharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM 10806X102 46,981 46,981 3,489 0.0452
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -20,317 -100.00 0 -100.00
2025-11-14 2025-09-30 13F BRIDGEBIO PHARMA COM 10806X102 20,317 20,317 1,055 0.0153
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM 10806X102 0 -26,323 -100.00 0 -100.00
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM 10806X102 26,323 -32,706 -55.41 910 -43.85 0.0240
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM 10806X102 59,029 -19,122 -24.47 1,620 -18.60 0.0399
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM 10806X102 78,151 -6,845 -8.05 1,990 -7.57 0.0453
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM 10806X102 84,996 17,355 25.66 2,153 2.92 0.0510
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM 10806X102 67,641 -36,724 -35.19 2,091 -50.37 0.0403
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM 10806X102 104,365 -100 -0.10 4,213 52.98 0.1075
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM 10806X102 104,465 15,507 17.43 2,755 80.00 0.0654
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM 10806X102 88,958 -33,775 -27.52 1,530 -24.78 0.0336
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM 10806X102 122,733 122,733 2,035 0.0417
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM 10806X102 0 -107,800 -100.00 0 -100.00
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM 10806X102 107,800 107,800 1,798 0.0423
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM Call 17,000 1,262 n/a n/a n/a
2025-08-14 2025-06-30 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F BRIDGEBIO PHARMA COM Call 192,600 -5.17 6,658 19.47 n/a n/a n/a
2025-02-14 2024-12-31 13F BRIDGEBIO PHARMA COM Call 203,100 5,573 n/a n/a n/a
2024-11-14 2024-09-30 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F BRIDGEBIO PHARMA COM Call 174,700 59.84 4,425 30.96 n/a n/a n/a
2024-05-15 2024-03-31 13F BRIDGEBIO PHARMA COM Call 109,300 3,380 n/a n/a n/a
2024-02-14 2023-12-31 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM Call 62,400 -75.07 1,645 -61.79 n/a n/a n/a
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM Call 250,300 -1.80 4,305 1.87 n/a n/a n/a
2023-05-15 2023-03-31 13F BRIDGEBIO PHARMA COM Call 254,900 4,226 n/a n/a n/a
2022-11-14 2022-09-30 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F BRIDGEBIO PHARMA COM Call 25,500 232 n/a n/a n/a
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM Call 28,200 470 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-11-14 2023-09-30 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F BRIDGEBIO PHARMA COM Put 30,000 516 n/a n/a n/a
2022-05-16 2022-03-31 13F BRIDGEBIO PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BRIDGEBIO PHARMA COM Put 210,800 3,516 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.